Impact Factor
4.29
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.18
5,464 total citations
h5-index
63
h5 depth signal
Cited share
85.4%
909 of 1,065
Total citations
5,464
Citation footprint
Metric signal
5.14
External metric anchor
Self-citation
4.9%
269 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,487
China
1,198
United Kingdom
327
Japan
310
Germany
261
Citing Fields of Research
Drug Delivery Systems
2,759
Polymer & Macromolecule Science
731
Nanoparticles
486
Radiation & Isotope-Based Techniques
403
Immunology
396
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
8,281
Articles tracked across the journal lifetime
Indexed publication set
1,065
909 cited publications
Last 12 months
551
45.9 publications/month
Open access share
18.1%
100 OA publications in the last year
Leading citing country
United States
1,487 citing publications
Leading citing field
Drug Delivery Systems
2,759 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Jan./Feb. 2004-
v1n1, Jan./Feb. 2004-
Active Coverage
Research Focus & Classification
Indexed Subjects
Drug Delivery Systems
Issuing & Sponsoring Bodies
Contributor
American Chemical Society
Broad Categories
Molecular Biology
Pharmacology
Drug Delivery Systems
MeSH Descriptors
Pharmaceutical Preparations
Pharmacology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1021/acs.molpharmaceut.6c00831
Open DOI
Molecular Insights into the Wet Granulation Mechanisms of Drugs with Different Solubilities
Wet granulation is an interfacial reconstruction process mediated by liquid binders. However, the mechanisms underlying the distinct granulation behaviors of drugs with different solubilities remain poorly understood due to a lack of mol...
02
DOI 10.1021/acs.molpharmaceut.6c00768
Open DOI
Monoclonal Antibody Coformulations Reveal Three Interaction Patterns Governing Stability
Coformulated monoclonal antibodies (mAbs) offer a promising next-generation therapeutic strategy by combining multiple antibodies in a single drug product to enhance efficacy and improve patient compliance. However, ensuring the quality ...
03
DOI 10.1021/acs.molpharmaceut.6c00761
Open DOI
PET Imaging of Dual GLP-1R and GIPR Targeting with [18F]AlF-NOTA-Asp2-Tirzepatide
Tirzepatide is a clinical dual GLP-1R and GIPR agonist for type 2 diabetes and obesity, and non-invasive approaches to assess its in vivo biodistribution and systemic toxicity in living animals remain limited. Both receptors also serve a...
04
DOI 10.1021/acs.molpharmaceut.6c00705
Open DOI
Fatty Acids for the Treatment of Ocular Diseases and Ocular Drug Delivery
The intricate anatomical and physiological barriers of the eye severely limit the bioavailability of conventional topical therapies, necessitating innovative strategies. In this review, fatty acids are presented as versatile agents funct...
05
DOI 10.1021/acs.molpharmaceut.6c00188
Open DOI
Theoretical Quantification of Cargo Effective Diffusivity in Affinity-Based Hydrogels
Affinity hydrogels enable precise control of cargo release kinetics through specific, non-covalent interactions between the functionalized polymer network and therapeutic agents. Yet, how these interactions integrate with steric hindranc...
06
DOI 10.1021/acs.molpharmaceut.6c01029
Open DOI
Image-Based Quantification of Amorphous Solid Dispersion Tablet Formulation Disintegration Profiles in a Custom USP-2 Apparatus
Amorphous solid dispersions (ASDs) are single-phase molecular mixtures of amorphous drug and polymer designed to enhance solubility, inhibit crystallization, and improve release rate, increasing bioavailability. During dissolution, water...
07
08
DOI 10.1021/acs.molpharmaceut.6c00601
Open DOI
Enhancing TB Therapy with Precision: Immunomodulatory Nanoparticles Co-Delivering Rifampicin and Vitamin D3 for Macrophage-Targeted Treatment
Tuberculosis (TB) remains a leading cause of death worldwide, with over 6.2 million cases and nearly 2 million deaths annually. Despite available chemotherapies, significant challenges persist, including prolonged treatment, poor complia...
09
DOI 10.1021/acs.molpharmaceut.6c00936
Open DOI
Mechanochemical Engineering of High-Dose Inhalable Antibiotic Powders for Lower Respiratory Tract Infections
Lower respiratory tract infections require high local antibiotic concentrations in the lung, yet current dry powder inhaler (DPI) technologies are poorly suited to delivering high drug payloads while maintaining particle stability, dispe...
10
DOI 10.1021/acs.molpharmaceut.6c01174
Open DOI
Preclinical Study of the 89Zr/177Lu-Labeled Engineered VHH-based Antibody for CLDN18.2-Targeted Radiotheranostics
Claudin 18.2 (CLDN18.2) is a tight junction protein aberrantly expressed in gastric and pancreatic cancer. In this study, we developed the novel nanobody 18.2−50H and VHH-Fc fusion antibody 18.2−50C radiolabeled with 89Zr/177Lu for CLDN1...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
v. 1, no. 1 (JAN 2004)20050330 Notice not published Printed on acid-free paper